Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses

被引:417
作者
Jeffrey, Kate L. [1 ]
Camps, Montserrat
Rommel, Christian
Mackay, Charles R.
机构
[1] Garvan Inst Med Res, Immunol & Inflammat Res Program, Sydney, NSW 2010, Australia
[2] Merck Serono SA, Merck Serono Res Ctr, CH-1202 Geneva, Switzerland
关键词
D O I
10.1038/nrd2289
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Dual-specificity phosphatases (DUSPs) are a subset of protein tyrosine phosphatases, many of which dephosphorylate threonine and tyrosine residues on mitogen-activated protein kinases (MAPKs), and hence are also referred to as MAPK phosphatases (MKPs). The regulated expression and activity of DUSP family members in different cells and tissues controls MAPK intensity and duration to determine the type of physiological response. For immune cells, DUSPs regulate responses in both positive and negative ways, and DUSP-deficient mice have been used to identify individual DUSPs as key regulators of immune responses. From a drug discovery perspective, DUSP family members are promising drug targets for manipulating MAPK-dependent immune responses in a cell-type and disease-context-dependent manner, to either boost or subdue immune responses in cancers, infectious diseases or inflammatory disorders.
引用
收藏
页码:391 / 403
页数:13
相关论文
共 169 条
  • [81] The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation
    Li, MX
    Zhou, JY
    Ge, YB
    Matherly, LH
    Wu, GS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 41059 - 41068
  • [82] Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling
    Lin, YW
    Yang, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) : 915 - 926
  • [83] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997)
    Lipinski, CA
    Lombardo, F
    Dominy, BW
    Feeney, PJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 3 - 26
  • [84] Dual-specificity phosphatases as targets for antineoplastic agents
    Lyon, MA
    Ducruet, AP
    Wipf, P
    Lazo, JS
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (12) : 961 - 976
  • [85] Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability
    Mahtani, KR
    Brook, M
    Dean, JLE
    Sully, G
    Saklatvala, J
    Clark, AR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) : 6461 - 6469
  • [86] Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5
    Mandl, M
    Slack, DN
    Keyse, SM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (05) : 1830 - 1845
  • [87] CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential
    Manzano, RG
    Montuenga, LM
    Dayton, M
    Dent, P
    Kinoshita, I
    Vicent, S
    Gardner, GJ
    Nguyen, PM
    Choi, YH
    Trepel, J
    Auersperg, N
    Birrer, MJ
    [J]. ONCOGENE, 2002, 21 (28) : 4435 - 4447
  • [88] Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6
    Marti, F
    Krause, A
    Post, NH
    Lyddane, C
    Dupont, P
    Sadelain, M
    King, PD
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 197 - 206
  • [89] Expression and comparative chromosomal mapping of MKP-5 genes DUSP10/Dusp10
    Masuda, K
    Shima, H
    Kikuchi, K
    Watanabe, Y
    Matsuda, Y
    [J]. CYTOGENETICS AND CELL GENETICS, 2000, 90 (1-2): : 71 - 74
  • [90] MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein
    Masuda, K
    Shima, H
    Watanabe, M
    Kikuchi, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 39002 - 39011